Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.
about
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formationInfusion of mature megakaryocytes into mice yields functional platelets.Qualitative disorders of platelets and megakaryocytes.Inherited platelet disorders: thrombocytopenias and thrombocytopathies.Current Strategies in Diagnosis of Inherited Storage Pool DefectsPlatelet disorders in children: A diagnostic approach.Inherited platelet disorders: a clinical approach to diagnosis and management.Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studies.The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment.The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO.Multimerin 1.Improving blood disorder diagnosis: reflections on the challenges.Platelet secretion: From haemostasis to wound healing and beyond.Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.Platelet-delivered therapeutics.Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytesDiagnosis and Management of Inherited Platelet Disorders.Coagulation factor XIIIa is inactivated by plasmin.Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.Guidelines for the laboratory investigation of heritable disorders of platelet function.The value of proteomics for the diagnosis of a platelet-related bleeding disorder.Thrombopoietin levels in Quebec platelet disorder-Implications for the mechanism of thrombocytopenia.Quebec platelet disorder.Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis.
P2860
Q27331904-48C98AB8-CDAC-48F2-97AC-C5195E8904EBQ30497158-7DA767E9-54BC-4C4F-BB15-BE29266BE3D5Q33367864-7725D409-01EB-4C30-843C-4AACEEF48139Q33387543-018874E3-0FA8-4C17-B1B9-839FEAFCBBC7Q33393005-C32E430B-25F2-4CB5-8FB6-17C70D33F00AQ33393990-46C0C7D6-0645-4D42-87DD-38598758E096Q33396427-159608E7-FD9F-4446-B4E5-89F2DDB0C57EQ33401969-E3D2A4DE-83C4-4BEF-BADD-ACCF1D518D79Q34929081-43021D72-37C6-4D61-9310-C7D8F4BF9430Q36310829-82C2F84A-0BF7-4438-986A-5891D37812B9Q36473090-E956D99F-6E87-4F02-A20E-8E3C35508DC1Q36514469-028988E5-58AD-4FD8-96DA-98C2254F7F7AQ36654370-0C8533D6-470C-458F-BF4A-A972BB290939Q37093683-376AECC9-9159-4E43-9085-3C76A9E78652Q38088277-8D563451-90FD-4CEE-8B41-3028DAF5FDB1Q38281989-E6DCC6F5-2B13-4AF6-B3DB-E4D3C148DBEBQ38447382-E78978A6-F4A0-4E51-A67E-07D3EECDCF82Q38543281-CD8DCF82-4216-4BF9-A821-C037302C4936Q41769044-52EE963F-6733-4FD2-958D-8019578C2BA9Q41926876-7AB1B5B2-DA05-4AA1-99F4-C51BE0BC67C0Q42246877-24920DC4-7EB0-45EB-9260-C7A05F48EB1BQ43179394-D55D40A1-34A4-48F8-8FDA-63911858E0B7Q45872104-F3882DD1-1E9D-4005-829A-E631280BF163Q46367580-28AFE688-9DCA-4FD9-A69F-59FC7E087E92Q48125691-A369BF7E-1015-4913-8F05-E1EDA7EAC3FAQ51870510-8C322091-86C9-45E0-999F-52A99BD0AE4EQ52570780-28F624F6-C928-48DC-964C-EDCE6BCCF402
P2860
Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Platelets from patients with t ...... se-type plasminogen activator.
@en
Platelets from patients with t ...... se-type plasminogen activator.
@nl
type
label
Platelets from patients with t ...... se-type plasminogen activator.
@en
Platelets from patients with t ...... se-type plasminogen activator.
@nl
prefLabel
Platelets from patients with t ...... se-type plasminogen activator.
@en
Platelets from patients with t ...... se-type plasminogen activator.
@nl
P2093
P356
P1433
P1476
Platelets from patients with t ...... se-type plasminogen activator.
@en
P2093
Bouchard M
Hayward CP
P304
P356
10.1182/BLOOD.V98.2.257
P407
P577
2001-07-01T00:00:00Z